A.Three works are here reported as performed on mite’s allergic patients at the Allergy Centre of Merate Hospital - Italy. These studies have been published at the European Congress of Allergology and Clinical Immunology.
The attached documentation is concerning the tests performed by Prof. L. Suss and Prof. G. Lozzia at the University of Milan – Italy.
Briefly the aim and the conclusions of the works:
trial #1: "Ultrasonic waves as an environmental protection measure against house dust mites”.
Aim: evaluation of electronic device's effectiveness in reducing both symptoms and drugs’ use.
Patients: 20 patients using the electronic device for a 3 months period + 20 patients as control group.
Results: a 28% decrease in days with symptoms and a 22% decrease in drugs’ intake, in the group of patients who used the electronic device.
Conclusions: the Authors explain the results, thanks to a possible action on mite’s fecal pellet that is rich in allergens.
trial #2: "A comparison between 2 means of environmental protection against mites: mattress cover vs. ultrasonic wave emitter”.
Aim:comparison of electronic device's vs. cover mattress’ effectiveness in reducing both symptoms and drugs’ use.
Patients: 15 patients using the electronic device for a 6 months period + 15 patients using a cover mattress + 15 patients as control group.
Results: same decrease in days with symptoms (16%) in the group with the electronic device and in the group with the cover mattress, compared to the control group.
The decrease in drugs’ consumption was also similar (about 10% compared to the control).
Conclusions: Both the cover mattress and the electronic device show their validity in reducing symptoms and drugs.
trial #3:"A comparison between an ultrasonic wave emitter and a chemical acaricide in implementing environmental protection against mites”.
Aim: comparison of electronic device’s vs. acaricide’s effectiveness in reducing both symptoms-drugs and mites’ presence in houses.
Patients: 16 patients using the electronic device for a 5 months period + 16 patients using an acaricide + 16 patients as control group.
Results: similar decrease in days with symptoms (about 19%) in the group with the electronic device and in the group with the acaricide, compared to the control group.
The decrease in drugs’ use was also similar (about 10% compared to the control).
About a 20% reduction in presence of mites inside patients’ homes was observed, in the group using the electronic device or the acaricide, compared to the control group.
Conclusions: Both the acaricide and the electronic device show their validity in reducing symptoms and drugs. Both the methods are able to control mites’ presence in houses. |